Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Acotec Scientific Holdings Limited 6669.HK
$15.12
-$0.12 (-0.79%)
На 18:04, 12 мая 2023
Ключевые показатели
-
Marketcap
4700834880.00000000
-
week52high
19.88
-
week52low
5.01
-
Revenue
395545000
-
P/E TTM
55
-
Beta
0.00000000
-
EPS
0.26000000
-
Last Dividend
0.00000000
-
Next Earnings Date
23 мар 2023 г. в 13:00
Описание компании
Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии